Longboard Pharmaceuticals Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
33
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.35B
- Investors
-
1
Longboard Pharmaceuticals General Information
Description
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
Contact Information
Website
www.longboardpharma.com(Operating Subsidiary)
Corporate Office
- 4275 Executive Square
- Suite 950
- La Jolla, CA 92037
- United States
Corporate Office
- 4275 Executive Square
- Suite 950
- La Jolla, CA 92037
- United States
Longboard Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 02-Dec-2024 | $2.35B | Completed | Generating Revenue | ||
| 6. PIPE | 01-Mar-2024 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Open Market | 26-Jan-2024 | Completed | Generating Revenue | |||
| 4. 2PO | 04-Jan-2024 | Completed | Generating Revenue | |||
| 3. 2PO | 08-Feb-2023 | Completed | Generating Revenue | |||
| 2. IPO | 12-Mar-2021 | $80M | $136M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 28-Oct-2020 | $56M | $56M | Completed | Startup |
Longboard Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Longboard Pharmaceuticals Comparisons
Industry
Financing
Details
Longboard Pharmaceuticals Competitors (2)
One of Longboard Pharmaceuticals’s 2 competitors is Neurogene, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurogene | Formerly VC-backed | New York, NY | ||||
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA |
Longboard Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Longboard Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Longboard Pharmaceuticals Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arena Pharmaceuticals | Corporation | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| HBM Healthcare Investments | Venture Capital | Minority | ||
| HBM Partners | Venture Capital | Minority | ||
| Highside Capital Management | Hedge Fund | Minority |
Longboard Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
19.36 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Longboard Pharmaceuticals FAQs
-
When was Longboard Pharmaceuticals founded?
Longboard Pharmaceuticals was founded in 2020.
-
Where is Longboard Pharmaceuticals headquartered?
Longboard Pharmaceuticals is headquartered in La Jolla, CA.
-
What is the size of Longboard Pharmaceuticals?
Longboard Pharmaceuticals has 33 total employees.
-
What industry is Longboard Pharmaceuticals in?
Longboard Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Longboard Pharmaceuticals a private or public company?
Longboard Pharmaceuticals is a Private company.
-
What is the current valuation of Longboard Pharmaceuticals?
The current valuation of Longboard Pharmaceuticals is .
-
What is Longboard Pharmaceuticals’s current revenue?
The current revenue for Longboard Pharmaceuticals is .
-
How much funding has Longboard Pharmaceuticals raised over time?
Longboard Pharmaceuticals has raised $429M.
-
Who are Longboard Pharmaceuticals’s investors?
Arena Pharmaceuticals, Cormorant Asset Management, HBM Healthcare Investments, HBM Partners, and Highside Capital Management are 5 of 6 investors who have invested in Longboard Pharmaceuticals.
-
Who are Longboard Pharmaceuticals’s competitors?
Neurogene and Neurona Therapeutics are competitors of Longboard Pharmaceuticals.
-
When was Longboard Pharmaceuticals acquired?
Longboard Pharmaceuticals was acquired on 02-Dec-2024.
-
Who acquired Longboard Pharmaceuticals?
Longboard Pharmaceuticals was acquired by H. Lundbeck.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
